Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment

NCT00977444 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: kondrium
DRUG: kondrium f
DRUG: methyl prednisolone (corticosteroid)

Sponsor

Nucitec

Collaborators

[object Object]